Abstract 3097: Preclinical characterization of MBS309, a PD-1-targeted and α-biased IL-2, demonstrating robust anti-tumor activity and a favorable safety profile
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Jiangmei Li, Guangzhong Lin, Lunfeng Zhang, Shuo Huang, Shuang Qing, Feng Li, Mingze Sun, Hong Chen
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148796196
Cites:
Cited by:
Related to: